<?xml version="1.0" encoding="UTF-8"?>
<p id="p0045">While NCI has moved swiftly, sometimes in a matter of days, to develop and launch new research efforts to address the pandemic, we understand that we won’t be successful alone. That’s why we are expanding our robust partnerships and collaborative relationships with other federal entities, public health institutions, and private sector companies to expedite progress in understanding, treating, and preventing the deadly viral disease. Many scientists and clinicians within NCI’s large networks of academic centers are experienced in conducting complex clinical trials and are temporarily pivoting some cancer research activities, including clinical trials, epidemiological studies, and basic research, to examine the impact of SARS-CoV-2 on cancer.</p>
